Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 2COHANCE LIFESCIENCES LIMITED
02 1AX Pharmaceutical Corp
03 1Darmerica, LLC
04 1Dipharma Francis Srl
05 1Fagron Inc
06 2Glenmark Life Sciences Limited
07 1Hetero Labs Limited
08 1Juzen Chemical Corporation
09 1MEDISCA Inc.
10 1Maithri Drugs Private Limited
11 1Professional Compounding Centers of America dba PCCA
12 1SUN PHARMACEUTICAL INDUSTRIES, INC.
13 1Sumitomo Pharma Co., Ltd.
14 1Zydus Lifesciences Limited
01 2ZONISAMIDE
02 14Zonisamide
01 1Canada
02 8India
03 1Italy
04 2Japan
05 1Netherlands
06 2U.S.A
07 1United Kingdom
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-137
Start Marketing Date : 2018-10-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1012
Start Marketing Date : 2018-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0063
Start Marketing Date : 2005-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1572
Start Marketing Date : 2019-04-15
End Marketing Date : 2025-03-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 59361-002
Start Marketing Date : 2005-02-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3045
Start Marketing Date : 2018-04-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-4807
Start Marketing Date : 2015-05-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38217-0040
Start Marketing Date : 2019-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62756-334
Start Marketing Date : 2023-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65841-125
Start Marketing Date : 2024-09-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Zonisamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zonisamide, including repackagers and relabelers. The FDA regulates Zonisamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zonisamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zonisamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zonisamide supplier is an individual or a company that provides Zonisamide active pharmaceutical ingredient (API) or Zonisamide finished formulations upon request. The Zonisamide suppliers may include Zonisamide API manufacturers, exporters, distributors and traders.
click here to find a list of Zonisamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zonisamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zonisamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zonisamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zonisamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zonisamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zonisamide suppliers with NDC on PharmaCompass.
We have 14 companies offering Zonisamide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
